Skip to content

A Study to Characterize Multidimensional Model to Predict the Course of Crohn's Disease (CD)

Characterization of a Multidimensional Model to Predict the Course of Crohn's Disease: A Pilot Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03668249
Acronym
PREMONITION-CD
Enrollment
5938
Registered
2018-09-12
Start date
2018-09-26
Completion date
2019-09-16
Last updated
2019-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn Disease, Inflammatory Bowel Diseases

Keywords

Drug therapy

Brief summary

The descriptive purpose of this study is to characterize clinical and nonclinical factors of participants with CD, participant flow and visits to other specialists in the hospitals of the healthcare network of the Autonomous Community of Madrid with implementation of electronic medical records. The clinical and nonclinical factors include: demographic and baseline clinical characteristics, lifestyle, relapses, complications, day hospital visits, surgery, presence of complications such as perianal fistulas and complex perianal fistulas. The predictive purpose of this study is to develop a statistical predictive model with the information obtained from the descriptive purpose, in the hospitals of the healthcare network of the Autonomous Community of Madrid, capable of assigning any participant diagnosed with CD a probability of reaching a prototypical clinical condition or a probability of experiencing certain clinical complications.

Detailed description

This is a retrospective and non-interventional study of participants with CD. The study will collect data from electronic medical records (EMRs) of the participants in the hospitals of the healthcare network of the Autonomous Community of Madrid with implementation of EMRs and will describe the determining factors and develop a statistical model for predicting likely outcomes in participants with CD. This study will conduct an additional substudy to evaluate the performance of the system through a human assessment to be performed by the clinical experts at each participating site. The study will have a retrospective data collection from EMRs of the participants referring to last 5 years. The study will enroll approximately 3000 participants. All participants will be enrolled in one observational cohort. This multi-center trial will be conducted in Spain. The overall time for data collection in the study will be approximately 5 years.

Interventions

None listed

Sponsors

Takeda
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 100 Years
Healthy volunteers
No

Inclusion criteria

1\. Diagnosed with CD from the medical centers participating in the study.

Design outcomes

Primary

MeasureTime frame
Number of Participants who Visit to Other SpecialistsApproximately 5 years
Number of day Hospital VisitsApproximately 5 years
Number of Participants who had SurgeriesApproximately 5 years
Number of Participants with Complications Such as Perianal Fistulas and Complex Perianal Fistulasapproximately 5 years
Participant FlowApproximately 5 years
Number of Participants who had RelapsesApproximately 5 years
Number of Participants who had Disease Related ComplicationsApproximately 5 years

Secondary

MeasureTime frameDescription
Number of Essential Factors on Which Physician's Predictions of Participant Outcomes are BasedApproximately 5 years
Prevalence of the Different PhenotypesApproximately 5 yearsDevelopment of a statistical predictive model capable of assigning any patient diagnosed with CD a probability of reaching a prototypical clinical condition or a probability of experiencing certain clinical complications.
Number of Participants who met the Eligibility Criteria to Receive Biological Treatment for CDApproximately 5 years
Number of Direct and Indirect Resources UsedApproximately 5 yearsHealth care resources of participants with CD will be assessed in terms of direct and indirect resources. Direct resources will include number of hospital admissions, emergency and hospital visits, and tests performed, etc. Indirect resources related to decreased productivity of CD participants through a specific variable, the total number of work days lost due to CD during the study period.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026